SEC 13F Intelligence

Ghost Tree Capital, LLC / ALNY

Ghost Tree Capital, LLC’s Alnylam Pharmaceuticals Inc Position

Does Ghost Tree Capital, LLC own Alnylam Pharmaceuticals Inc (ALNY)? Not currently — the last reported position was 22.5K shares worth $5M in Q2 2024; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$5M
Q2 2024
Shares
22.5K
% of Portfolio
+1.71%
Quarters Held
8
position exited

Position History ALNY

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $14MQ1 ’19Q2 ’19: $11MQ2 ’19Q4 ’21: $5MQ4 ’21Q2 ’22: $277,000Q2 ’22Q4 ’23: $5MQ4 ’23Q1 ’24: $9MQ1 ’24Q2 ’24: $5MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202422.5K$5M+1.71%
Q1 202460.0K$9M+2.48%
Q4 202327.5K$5M+1.72%
Q2 20221.9K$277,000+0.14%
Q4 202130.0K$5M+1.82%
Q2 2019150.0K$11M+2.28%
Q1 2019150.0K$14M+3.80%
Q4 201835.0K$3M+0.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of ALNY.